GlassScriptPhysician profile
Duane F Cumberbatch
NPI 1477511350
$17,720.82
in general payments reported to CMS, 2019-2025
46 companies · $370 in 2025
The $370 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,606 · 2020: $2,216 · 2021: $1,632 · 2022: $1,939 · 2023: $1,107 · 2024: $3,851 · 2025: $370.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,113 · Travel and Lodging: $1,389 · Consulting Fee: $798 · Education: $27.54.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,113.21 |
| Travel and Lodging | $1,389.24 |
| Consulting Fee | $798.00 |
| Education | $27.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acell, INC. | $3,056.86 | 2019-2020 | |
| Arthrex, INC. | $2,997.00 | 2019-2023 | |
| Smith+Nephew, INC. | $1,863.16 | 2021-2024 | Q-Fix, Ultrabutton, Bone Anchors With Arthroscopic Delivery System |
| Aroa Biosurgery Incorporated | $1,443.43 | 2022-2024 | |
| Wright Medical Technology, INC. | $1,113.73 | 2019-2020 | |
| Paragon 28, INC. | $994.15 | 2019 | |
| Royal Biologics, INC. | $878.46 | 2024 | |
| Treace Medical Concepts, INC. | $682.16 | 2021-2025 | |
| Stryker Corporation | $606.77 | 2019-2021 | |
| Organogenesis INC. | $565.09 | 2019-2021 | |
| Boston Scientific Corporation | $443.25 | 2020-2025 | Intracept |
| Biocomposites INC | $435.49 | 2019 | |
| Abbvie INC. | $361.79 | 2022-2024 | Dalvance |
| W. L. Gore & Associates, INC. | $187.55 | 2023 | Gore Excluder Aaa Endoprosthesis |
| Horizon Therapeutics Plc | $171.66 | 2021 |
Show all 46 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Reprise Biomedical, INC. | $170.57 | 2023 | Miro3d |
| Novastep INC. | $169.95 | 2021 | |
| Bioventus LLC | $158.37 | 2020-2021 | |
| Integra Lifesciences Corporation | $141.16 | 2021 | |
| Curonix LLC | $108.14 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Innovation Technologies INC | $107.56 | 2023 | Irrisept |
| Abbott Laboratories | $104.53 | 2021 | |
| Crossroads Extremity Systems, LLC | $100.00 | 2020 | |
| Cardiovascular Systems INC. | $94.02 | 2019 | |
| Mvp Orthopedics INC | $70.89 | 2021-2022 | |
| Acumed LLC | $54.93 | 2021 | |
| Ermi LLC | $53.25 | 2019 | |
| Paratek Pharmaceuticals, INC. | $52.16 | 2023-2024 | Nuzyra |
| Kci USA, INC. | $49.38 | 2019-2020 | |
| Grt US Holding, INC. | $45.98 | 2021-2022 | |
| Next Science LLC | $41.25 | 2023 | Surgx, Blastx, Xperience |
| Ossio INC | $40.66 | 2022 | |
| Melinta Therapeutics, LLC | $39.46 | 2019 | |
| Stimwave Technologies Incorporated | $37.54 | 2020-2021 | |
| Orthofix Medical, INC. | $36.13 | 2021 | |
| Merck Sharp & Dohme LLC | $35.63 | 2019 | |
| Medtronic, INC. | $35.31 | 2023-2024 | Intellis Adaptivestim, Closurefast |
| Djo, LLC | $25.13 | 2023 | Cmf |
| Averitas Pharma INC. | $23.93 | 2025 | Qutenza |
| Kerecis Limited | $23.92 | 2021 | |
| Nevro Corp. | $20.73 | 2023 | Senza |
| Heron Therapeutics, INC. | $18.70 | 2021 | |
| Solventum Corporation | $17.43 | 2024 | Activ.A.C. |
| Urgo Medical North America, LLC | $16.51 | 2024 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Nabriva Therapeutics, Plc | $14.82 | 2022 | |
| Fidia Pharma USA INC. | $12.23 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Duane Cumberbatch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.